相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A Systematic Review and Meta-Analysis on the Survival of Cancer Patients Treated with a FermentedViscum albumL. Extract (Iscador): An Update of Findings
Thomas Ostermann et al.
COMPLEMENTARY MEDICINE RESEARCH (2020)
Mistletoe in oncological treatment: a systematic review Part 1: survival and safety
M. Freuding et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2019)
Mistletoe in oncological treatment: a systematic review: Part2: quality of life and toxicity of cancer treatment
M. Freuding et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2019)
Letter to the editors of the Journal of Cancer Research and Clinical Oncology
H. Matthes et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2019)
Answer to the letter to the editors by Matthes and colleagues regarding our systematic reviews on mistletoe
Jutta Huebner et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2019)
Integrative cancer care in a certified Cancer Centre of a German Anthroposophic hospital
Anja Thronicke et al.
COMPLEMENTARY THERAPIES IN MEDICINE (2018)
Integrative Therapies During and After Breast Cancer Treatment: ASCO Endorsement of the SIO Clinical Practice Guideline
Gary H. Lyman et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Implementation of an Integrative Oncological Concept in the Daily Care of a German Certified Breast Cancer Center
Friedemann Schad et al.
COMPLEMENTARY MEDICINE RESEARCH (2018)
Use of biologically-based complementary medicine in breast and gynecological cancer patients during systemic therapy
Loisa Drozdoff et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2018)
Real-world Data for Clinical Evidence Generation in Oncology
Sean Khozin et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both
Beverley J. Shea et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both
Beverley J. Shea et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Real-world Data for Clinical Evidence Generation in Oncology
Sean Khozin et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Clinical Practice Guidelines on the Evidence-Based Use of Integrative Therapies During and After Breast Cancer Treatment
Heather Greenlee et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Quality of Life of Patients With Advanced Pancreatic Cancer During Treatment With Mistletoe A randomized controlled trial
Wilfried Troeger et al.
DEUTSCHES ARZTEBLATT INTERNATIONAL (2014)
Adverse Drug Reactions and Expected Effects to Therapy with Subcutaneous Mistletoe Extracts (Viscum album L.) in Cancer Patients
Megan L. Steele et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2014)
A Randomized Study on Postrelapse Disease-Free Survival with Adjuvant Mistletoe versus Oral Etoposide in Osteosarcoma Patients
Alessandra Longhi et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2014)
Additional Therapy with a Mistletoe Product during Adjuvant Chemotherapy of Breast Cancer Patients Improves Quality of Life: An Open Randomized Clinical Pilot Trial
Wilfried Troeger et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2014)
Cross-sectional study of self-reported physical activity, eating habits and use of complementary medicine in breast cancer survivors
Arnoud J. Templeton et al.
BMC CANCER (2013)
Mistletoe as complementary treatment in patients with advanced non-small-cell lung cancer treated with carboplatin-based combinations: A randomised phase II study
Gil Bar-Sela et al.
EUROPEAN JOURNAL OF CANCER (2013)
Viscum album [L.] extract therapy in patients with locally advanced or metastatic pancreatic cancer: A randomised clinical trial on overall survival
W. Troeger et al.
EUROPEAN JOURNAL OF CANCER (2013)
Prospective Controlled Cohort Studies on Long-term Therapy of Ovarian Cancer Patients with Mistletoe (Viscum album L.) Extracts Iscador
Ronald Grossarth-Maticek et al.
ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH (2012)
RETROLECTIVE STUDIES ON THE SURVIVAL OF CANCER PATIENTS TREATED WITH MISTLETOE EXTRACTS: A META-ANALYSIS
Thomas Ostermann et al.
EXPLORE-THE JOURNAL OF SCIENCE AND HEALING (2012)
Five-Year Follow-Up of patients with early stage Breast cancer After a Randomized study comparing Additional Treatment with Viscum Album (L.) extract to chemotherapy Alone
Wilfried Troger et al.
BREAST CANCER-BASIC AND CLINICAL RESEARCH (2012)
Safety of higher dosages of Viscum album L. in animals and humans - systematic review of immune changes and safety parameters
Gunver S. Kienle et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2011)
Survival of cancer patients treated with mistletoe extract (Iscador): a systematic literature review
Thomas Ostermann et al.
BMC CANCER (2009)
Viscum album L. extracts in breast and gynaecological cancers: a systematic review of clinical and preclinical research
Gunver S. Kienle et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2009)
Association of complementary methods with quality of life and life satisfaction in patients with gynecologic and breast malignancies
P. A. Fasching et al.
SUPPORTIVE CARE IN CANCER (2007)
Efficacy and Safety of the Long-term Treatment of Melanoma with a Mistletoe Preparation (Iscador)
Ronald Grossarth-Maticek et al.
SCHWEIZERISCHE ZEITSCHRIFT FUER GANZHEITSMEDIZIN (2007)
Prospective controlled cohort studies on long-term therapy of cervical cancer patients with a mistletoe preparation (Iscador((R)))
Ronald Grossarth-Maticek et al.
FORSCHENDE KOMPLEMENTARMEDIZIN (2007)
Prospective controlled cohort studies on long-term therapy of breast cancer patients with a mistletoe preparation (Iscador (R))
Ronald Grossarth-Maticek et al.
FORSCHENDE KOMPLEMENTARMEDIZIN UND KLASSISCHE NATURHEILKUNDE (2006)
Final results of the EORTC 18871/DKG 80-1 randomised phase III trial:: rIFN-α2b versus rIFN-γ versus ISCADOR M® versus observation after surgery in melanoma patients with either high-risk primary (thickness >3 mm) or regional lymph node metastasis
UR Kleeberg et al.
EUROPEAN JOURNAL OF CANCER (2004)
Oncologic mistletoe therapy -: physicians use and estimated efficiency
K Münstedt et al.
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT (2000)
分享论文
